Search in:

Advanced search

Current Medical Research and Opinion Volume 34, 2018 - Issue 7

Submit an article Journal homepage

185

Views

CrossRef citations to date

Altmetric

Neurology

Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson’s disease

Jan-Peer Elshoffa UCB Pharma, Monheim am Rhein, Germany; Correspondence[email protected]

Lars Bauera UCB Pharma, Monheim am Rhein, Germany;

Nadine Goldammera UCB Pharma, Monheim am Rhein, Germany;

Marga Oortgiesenb UCB Pharma, Raleigh, NC, USA;

Hanna Pescha UCB Pharma, Monheim am Rhein, Germany;

Lars Timmermannc Department of Neurology, University Hospital Cologne, Cologne, Germany

Pages 1293-1299 | Received 11 Aug 2017, Accepted 19 Dec 2017, Published online: 20 Feb 2018

Cite this article
https://doi.org/10.1080/03007995.2018.1430559
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Reprints & Permissions

References

European Medicines Agency. Neupro (rotigotine transdermal system) summary of product characteristics. 2016. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000626/WC500026397.pdf [Last accessed 17 February 2017]
Google Scholar
UCB. Neupro: US prescribing information. 2015. Available at: http://www.ucb.com/_up/ucb_com_products/documents/Neupro_Current_COL_02-2015.pdf [Last accessed 17 February 2017]
Google Scholar
Scheller D, Ullmer C, Berkels R, et al. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease. Naunyn Schmiedebergs Arch Pharmacol 2009;379:73-86
PubMed Web of Science ®Google Scholar
Elshoff JP, Braun M, Andreas JO, et al. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther 2012;34:966-78
PubMed Web of Science ®Google Scholar
Rozenberg A, Gurevich T, Giladi N, Korczyn AD. Gastric dysfunction in Parkinson’s disease. In: Pfeiffer RF, Bodis-Wollner I (eds.) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. New York: Springer Science + Business Media, 2013:145-54
Google Scholar
Cilurzo F, Gennari CG, Minghetti P. Adhesive properties: a critical issue in transdermal patch development. Expert Opin Drug Deliv 2012;9:33-45
PubMed Web of Science ®Google Scholar
Reeve A, Simcox E, Turnbull D. Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Res Rev 2014;14:19-30
PubMed Web of Science ®Google Scholar
Swinn L, Schrag A, Viswanathan R, et al. Sweating dysfunction in Parkinson’s disease. Mov Disord 2003;18:1459-63
PubMed Web of Science ®Google Scholar
Elshoff JP, Timmermann L, Schmid M, et al. Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations. Curr Med Res Opin 2013;29:1657-62
PubMed Web of Science ®Google Scholar
European Medicines Agency. EMA/CHMP/QWP/911254/2011. Guideline on quality of transdermal patches, Draft. 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/09/WC500132404.pdf [Last accessed 17 February 2017]
Google Scholar
FDA/CDER. Guidance for industry: skin irritation and sensitization testing of generic transdermal drug products. 1999. Available at: http://www.fda.gov/ohrms/dockets/98fr/990236Gd.pdf [Last accessed 17 February 2017]
Google Scholar
Lehmann EL. Nonparametrics: Statistical Methods Based on Ranks. New York: Springer, 2006
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson’s disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson’s disease

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date